4
Changes in Ownership
Kalaris Therapeutics, Inc. Filed Acc 0000950170-24-046908
Chief Executive Officer sold 9,601 shares at $0.75 ($7,207)
From the SEC's structured data for this filing
Trades in this filing
Brainard Diana · Chief Executive Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-04-19 | Sale : show line 1 in the form | −9,601 | $0.75 | $7,207 | 802,935 | D |
| Open-market sales · 9,601 sh · avg $0.75 · $7,207 | ||||||
Loading xslF345X05/ownership.xml…